The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases
- 17 March 2010
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Human Genetics
- Vol. 18 (7), 856-858
- https://doi.org/10.1038/ejhg.2010.29
Abstract
No study has evaluated the performance of BRCA1/2 mutations prediction models in male breast cancer (MBC) series. Although rare, MBC deserves attention because male and female breast cancers share many characteristics, including the involvement of genetic predisposition factors such as BRCA1/BRCA2 mutations. Indeed, the occurrence of MBC is a commonly used criterion to select families for BRCA mutation testing. We evaluated the performance and clinical effectiveness of four different predictive models in a population-based series of 102 Italian MBC patients characterized for BRCA1/2 mutations. Sensitivity, specificity, and positive and negative predictive values (PPV, NPV) were calculated for each risk model at the 10% threshold. The area under the ROC (AUC) curves and its corresponding asymptotic 95% CIs were calculated as a measure of the accuracy. In our study, the BRCAPRO version 5.0 had the highest combination of sensitivity, specificity, NPV and PPV for the combined probability and for the discrimination of BRCA2 mutations. In individuals with negative breast–ovarian cancer family history, BRCAPRO 5.0 reached a high discriminatory capacity (AUC=0.92) in predicting BRCA2 mutations and showed values of sensitivity, specificity, NPV and PPV of 0.5, 0.98, 0.97 and 0.67, respectively, for the combined probability. BRCAPRO version 5.0 can be particularly useful in dealing with non-familial MBC, a circumstance that often represents a challenging situation in genetic counseling.This publication has 23 references indexed in Scilit:
- Male breast cancerCritical Reviews in Oncology/Hematology, 2010
- Oral Contraceptive Use and BRCA Penetrance: A Case-Only StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- Performance of Prediction Models for BRCA Mutation Carriage in Three Racial/Ethnic Groups: Findings from the Northern California Breast Cancer Family RegistryCancer Epidemiology, Biomarkers & Prevention, 2009
- Tailoring BRCAPRO to Asian-AmericansJournal of Clinical Oncology, 2009
- BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central ItalyBreast Cancer Research and Treatment, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Assessing BRCA Carrier Probabilities in Extended FamiliesJournal of Clinical Oncology, 2006
- BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian familiesBreast Cancer Research, 2005
- A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics centerClinical Genetics, 2000
- Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2American Journal of Human Genetics, 1998